Hormone replacement therapy for women at menopause has been beset with issues over...
Flexible Drug Containers for Parenteral Drugs
Self-medication is becoming more popular, driven by cost considerations. Valuable time of healthcare personnel and the high cost of hospital stays are outweighing the costs of treatment drastically.
Dehumidified Air Ensures Quality Hormone Packaging for Orion Pharmaceuticals
Production of hormone medication involves packing in foil blister packs. The process includes cooling and requires very cold machine surfaces.
Otsuka expands digital medicines alliance with Proteus Digital
Otsuka Pharmaceutical has expanded its global collaboration agreement with Proteus Digital Health for advancing a portfolio of digital medicines and care models to help patients with severe mental illness.
Getting to the Bottom of Data Integrity: Four to Explore
NSF International Pharma has experienced that data integrity (DI) is usually the tip of a very big iceberg. Beneath the surface can be a number of contributing factors, rarely just one.
The highs and lows of hormone replacement therapy
Hormone replacement therapy for women at menopause has been beset with issues over the past few decades, from safety concerns to drug shortages and rising costs. What are the challenges for research and development in this area and what does the future hold for these drugs?
Guide to Selecting the Right Serialisation partner
For most pharmaceutical companies, it is becoming increasingly complex to stay up-to-date with compliant with the evolving requirements and guidance surrounding anti-counterfeiting regulations.
Sandoz launches second Healthcare Access Challenge
Novartis division Sandoz has launched its second Healthcare Access Challenge (HACk) aimed at supporting digital solutions intended to boost access to healthcare.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.